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Background: In non-excitable cells, one major route for calcium entry is through store-operated calcium (SOC)
channels in the plasma membrane. These channels are activated by the emptying of intracellular Ca2+ store.
STIM1 and Orai1 are major regulators of SOC channels. In this study, we explored the functions of STIM1 and
Orai1 in epidermal growth factor (EGF)-induced cell proliferation and migration in retinal pigment epithelial cells
(ARPE-19 cell line).
Results: EGF triggers cell proliferation and migration in ARPE-19 cells. Cell proliferation and migration involve STIM1
and Orai1, as well as phosphorylation of extracellular signal-regulated protein kinase (ERK) 1/2, and Akt.
Pharmacological inhibitors of SOC channels and siRNA of Orai1 and STIM1 suppress cell proliferation and migration.
Pre-treatment of mitogen-activated protein kinase kinase (MEK) inhibitors and a phosphatidylinositol 3 kinases (PI3K)
inhibitor attenuated cell proliferation and migration. However, inhibition of the SOC channels failed to prevent
EGF-mediated ERK 1/2 and Akt phosphorylation.
Conclusions: Our results showed that STIM1, Orai1, ERK 1/2, and Akt are key determinants of EGF-mediated cell
growth in ARPE-19 cells. EGF is a potent growth molecule that has been linked to the development of PVR, and
therefore, STIM1, Orai1, as well as the MEK/ERK 1/2 and PI3K/Akt pathways, might be potential therapeutic targets
for drugs aimed at treating such disorders.
Keywords: STIM1, Orai1, Store-operated calcium channel, Retinal pigment epithelial cell, Proliferative
vitreoretinopathyBackground
The retinal pigment epithelium (RPE) lying between the
neurosensory retina and the choroid is vital for normal
visual function [1]. Under normal conditions, the RPE
cells have limited potential for proliferation and migra-
tion. However, in response to trauma, inflammation, or
other extracellular stimuli, the RPE cells may proliferate
and migrate; this in turn leads to serious vitreoreti-
nal diseases such as proliferative vitreoretinopathy (PVR)
[2,3]. PVR is a complication of rhegmatogenous reti-
nal detachment with poor prognosis for visual function.
The pathogenesis of PVR comes from the retinal break
that exposes the vitreous to the RPE and causes the* Correspondence: wcc@kmu.edu.tw
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reproduction in any medium, provided the orbreakdown of the blood-retinal barrier [4]. The cyto-
kines in the plasma trigger proliferation and migration
of the RPE cells, thereby resulting in epiretinal mem-
brane formation, which complicates reattachment sur-
gery [4].
Several lines of evidence have indicated that epidermal
growth factor (EGF) is an important regulator in the
proliferation and migration of RPE cells during PVR
development [5]. For example, expression of EGF was
detected in the preretinal membranes, and intravitreal
and subretinal fluid cells from PVR patients [6,7]. Recent
studies have revealed that co-treatment with EGF and
transforming growth factor β1 (TGF-β1) increased the
expression of alpha-smooth muscle actin (α-SMA) [8],
which was expressed by myofibroblasts in epiretinal
membranes from patients with PVR [9]. Therefore, EGF
contributes to PVR development.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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calcium signaling via store-operated calcium (SOC)
channels [10,11] and subsequent regulation of cell pro-
liferation and migration [12]. Calcium plays an impor-
tant role in the development and maintenance of many
physiological functions [13], and therefore, the intracel-
lular calcium concentration is precisely regulated. An in-
crease in the intracellular calcium concentration results
in altered cellular functions such as cell proliferation,
cytokines secretion, DNA synthesis, and cell migration
[14]. In non-excitable cells, SOC channels are critical
modulators of intracellular calcium signaling. Orai1 is a
key subunit of SOC channels whereas stromal interac-
tion molecule 1 (STIM1) is a calcium sensor that trig-
gers the activation of SOC channels [15]. Recently, both
Orai1 and STIM1 have been identified in RPE cells [14].
However, the roles of STIM1 and Orai1 in the growth of
RPE cells are still elusive.
In this study, we hypothesized that STIM1/Orai1-
mediated calcium signaling is involved in EGF-induced
cell proliferation and migration in ARPE-19 cells. To test
this hypothesis, SOC channel inhibitors and small inter-
fering RNA (siRNA) of Orai1 and STIM1 were used to
examine the mechanisms of cell proliferation and migra-
tion in ARPE-19 cells. The findings of this study provide
further insight into the pathogenesis of PVR.
Methods
Cell culture
ARPE-19 cells were obtained from the American
Type Culture Collection (ATCC) and maintained in
Dulbecco’s Modified Eagle’s Medium: F-12 (DMEM:F-12)
nutrient mixture (Invitrogen Corp., Carlsbad, CA) with
10% fetal bovine serum (FBS) (Invitrogen Corp., Carlsbad,
CA), 100 mg/mL streptomycin and 100 U/mL penicillin
(Invitrogen Corp., Carlsbad, CA) at 37°C with 5% CO2. In
cell proliferation studies, cells were starved with 0.5% FBS
in DMEM:F12 for 24 h before EGF treatment.
WST-1 assay
ARPE-19 cells were pre-treated for 30 min with various
inhibitors and then exposed to EGF (25 ng/mL) for 48 h.
To assay cell proliferation, cells were incubated with
WST-1 reagent (Roche, Indianapolis, IN) at 37°C for 5
to 10 min. A microplate spectrophotometer was used to
measure the absorbance of the samples at 450 nm with
600 nm as the reference wavelength.
Wound healing assay
ARPE-19 cells were seeded in wells of Culture-Insert
(Ibidi GmbH, Martinsried, Germany) for 24 h. The
Culture-Inserts were removed to reveal the wound gap.
The baseline and the wound closure after treatment
were photographed at magnification of 100× by a digitalcamera attached to an inverted microscope (Nikon
Eclipse Ti, Nikon, Japan). The photos shown were repre-
sentative of three independent experiments. For further
quantitative analyses, distances between the two edges of
the gap in five fields were measured and were used to
calculate the relative migration percentage using the fol-
lowing formula: Relative migration percentage = (the dis-
tance before migration - the distance after migration)/
the distance before migration × 100%.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from ARPE-19 cells with Trizol
reagent (Invitrogen Corp., Carlsbad, CA) according to
the manufacturer’s instructions. Reverse transcriptase
reactions were performed on 1 μg samples of RNA using
a reverse transcription kit (Invitrogen Corp., Carlsbad,
CA). Incubation conditions included 10 min at 25°C,
120 min at 37°C, and 5 min at 85°C. The resulting
cDNAs were used to detect Orai1 and STIM1 expres-
sion levels by PCR.
PCR and DNA gel electrophoresis
After synthesis of cDNA, we used the following gene-
specific primers: Orai-1 (196 bp), forward primer: TTC
CTA GCT GAG GTG GTG CT; reverse primer: CGA
TAA AGA TCA GGC CGA AG; STIM 1 (563 bp), for-
ward primer: GGC AGT ACA CGC CCC AAC CC; re-
verse primer: CCA GCC AGG TGG GGA ATG CG.
After denaturing the DNA at 94°C for 5 min, thirty-five
cycles of amplification were performed: 94°C 30 sec,
58°C 30 sec, 72°C 1 min. Then the reaction was incu-
bated at 72°C for 10 min. PCR products were separated
by gel electrophoresis in 2% DNA agarose gel using TAE
buffer and visualized by ethidium bromide staining and
UV transillumination.
Protein extraction and western blotting
Total cell lysates (40 μg) were isolated in RIPA buffer
containing protease inhibitors and analyzed by SDS-
PAGE on a 10% gel. After electro-blotting onto polyvi-
nylidene fluoride membranes (Millipore Corp., Bedford,
MA), membranes were blocked with 5% non-fat dry
milk for 1 h at room temperature. Blots were probed
overnight at 4°C with working dilutions of primary
antibodies specific for the individual target protein. The
dilution of antibody against Orai1 (Santa Cruz Biotech-
nology, Santa Cruz, CA) was 1:500. The dilution of anti-
body against STIM1 (BD Transduction Laboratories,
Franklin Lakes, NJ) was 1:250. The dilution of antibody
against β-actin (Sigma-Aldrich, Saint Louis, MO) was
1:20000. The dilution of antibody against phospho-ERK
1/2 (Millipore Corp., Bedford, MA or Cell Signaling,
Beverly, MA) was 1:1000. The dilution of antibody
against phospho-Akt (Epitomics, Burlingame, CA) was
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PBST and incubated with a 1:2000 to 1:10000 dilution of
peroxidase-linked anti-rabbit or anti-mouse IgG secon-
dary antibodies (Millipore Corp., Bedford, MA) for 1 h
at room temperature. Last, the protein bands were vi-
sualized using an ECL-plus Western blotting detection
system (Millipore Corp., Bedford, MA).
Calcium concentration detection
ARPE-19 cells were seeded onto glass coverslips for 24
h. Then the attached cells were loaded with 1 μM Fluo-4
(Invitrogen Corp., Carlsbad, CA) at 37°C for 20 min in
the dark. Cells were washed three times in standard ex-
ternal solution: 145 mM NaCl, 2.8 mM KCl, 2 mM
CaCl2, 2 mM MgCl2, 10 mM D-glucose, and 10 mM
HEPES, pH 7.4. Changes in fluorescence intensity of
Fluo-4 in loaded cells were detected by time-lapse video-
microscope (Olympus IX70, Olympus, Japan) and ana-
lyzed by the cellΛR system (Olympus, Japan).
Transfection with siRNA
ARPE-19 cells were seeded for 24 h. Then, the cells were
transiently transfected with control siRNA (Santa Cruz
Biotechnology, Santa Cruz, CA), Orai1 siRNA (Santa
Cruz Biotechnology, Santa Cruz, CA; Applied Biosys-
tems, Foster City, CA), or STIM1 siRNA (Santa Cruz
biotechnology, Santa Cruz, CA; Applied Biosystems,
Foster City, CA) in Opti-MEM medium (Invitrogen
Corp., Carlsbad, CA) containing Lipofectamine™ 2000Figure 1 EGF induced ARPE-19 cell proliferation and migration. (A) W
ARPE-19 cells was induced after EGF treatment for 24 h and 48 h (both **
25 ng/mL EGF stimulation. (C) The quantitative analysis of Figure 1B reveal
(* p < 0.05 and ** p < 0.01, respectively).(Invitrogen Corp., Carlsbad, CA). In two consecutive
days following transfection (transfecting once every
24 h), the cells were treated and prepared for indi-
vidual experiments.
Quantitative real-time PCR
The primers used: Orai-1 (196 bp) as previously des-
cribed; β-actin (145 bp), forward primer: ATC TCC
TTC TGC ATC CTG TCG GCA AT; reverse primer:
CAT GGA GTC CTG GCA TCC ACG AAA C; and
STIM 1 (110 bp), forward primer: AGA AAC ACA CTC
TTT GGC ACC; reverse primer: AAT GCT GCT GTC
ACC TCG. The SYBR Green PCR master mix reagent
(Applied Biosystems, Foster City, CA) was used to amp-
lify the cDNA and the products were detected by Ap-
plied Biosystems 7500.
BrdU (Bromodeoxyuridine) assay
DNA synthesis in proliferating cells was determined
by measuring BrdU incorporation with the commercial
Cell Proliferation ELISA System (Roche, Indianapolis,
IN). ARPE-19 cells were seeded at a density of 3 × 103
per well using 96-well culture plates in 10% FBS with
DMEM:F12 for 24 h. For the inhibitor study, the cells
were then starved with 0.5% FBS in DMEM:F12 for an-
other 24 h before inhibitors pre-treatment and then EGF
(25 ng/mL) treatment for 24 h. For the siRNA study, the
cells were transiently transfected with siRNA, and then
treated with EGF (25 ng/mL) for 24 h. The cells wereST-1 assay was used to test cell proliferation. Cell proliferation of
p < 0.01). (B) Cell migration was increased after 24 h and 48 h of
ed significant cell migration induced by the treatment of EGF
Figure 2 Calcium chelators reduced the EGF-mediated cell proliferation and migration in the ARPE-19 cells. (A) Pre-treatment of EGTA
(1 mM) or BAPTA-AM (2.5 μM) inhibited EGF-stimulated cell proliferation (*** p < 0.001 and ** p < 0.01, respectively) by WST-1 assay. (B) EGTA
(1 mM) and BAPTA-AM (5 μM) suppressed EGF-mediated ARPE-19 cell migration. (C) The quantitative analysis of Figure 2B showed the statistical
significance of suppression in EGF-mediated cell migration by EGTA and BAPTA-AM.
Figure 3 The expression of STIM1 and Orai1 in ARPE-19 cells. (A, B) Expression of Orai1 and STIM1 was determined by RT-PCR (A) and
Western blots (B) in ARPE-19 cells. (C) Fluorescent-based calcium assay was used to detect calcium signals. ARPE-19 cells were incubated in
calcium free condition with 2 μM thapsigargin (TG). And then 2 mM calcium solution was added to detect the classical SOC entry.
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1X BrdU labeling agent (Roche, Indianapolis, IN). The
subsequent FixDenat, Anti-BrdU-peroxidase-conjugate,
and substrate treatment procedures were performed
according to the manufacturer’s instructions. Absorb-
ance values were measured at 405 nm using a micro-
plate spectrophotometer.
Flow cytometry
ARPE-19 cells were seeded in 10-cm dishes until 80%
confluence. Cells were starved for 24 h with 0.5% FBS in
DMEM:F12 before inhibitor pre-treatment and then
EGF (25 ng/mL) treatment for 24 h. The cells were then
harvested by trypsin treatment, collected in 15-mL cen-
trifuge tubes and washed with PBS. The collected cells
were fixed at −20°C with 70% ethanol for more than 1 h.
After fixation, the ethanol was removed from fixed cells
by centrifugation. The fixed cells were then incubated
with 1 mL of propidium iodide staining solution for
30 min at room temperature in the dark. The per-
centage of cells in each phase of the cell cycle wasFigure 4 The inhibitor of SOC channels inhibited EGF-mediated cell p
by 2 μM TG was suppressed by adding 100 μM 2-APB in ARPE-19 cells. (B)
then were incubated with 25 ng/mL EGF for 48 h. WST-1 assay was used in
30 min, and were stimulated by 25 ng/mL EGF for 24 h and 48 h. Wound h
Figure 4C showed the statistical significance of reduction in EGF-mediateddetermined by flow cytometry (BD Biosciences, Franklin
Lakes, NJ). Approximately 10,000 events (cells) were eval-
uated for each sample.
Statistical analysis
All data are shown as means ± SD in figures. Statistical
analyses were performed using the Statistical Package
for Social Science program (SPSS for Windows, version
13.0; SPSS, Chicago, IL) based on the results of six inde-
pendent experiments. One-way ANOVA was used for
comparing the differences between groups. P values less
than 0.05 were considered statistically significant.
Results
EGF stimulated cell proliferation and migration in
ARPE-19 cells
First, we assessed the effects of EGF on ARPE-19 cell
proliferation and migration by WST-1 assay and wound
healing assay, respectively. Statistically significant in-
creases in cell proliferation were observed following
24 h and 48 h stimulation with 25 ng/mL of EGFroliferation and migration in ARPE-19 cells. (A) SOC influx evoked
ARPE-19 cells were pre-treated with 100 μM 2-APB for 30 min and
this study. (C) ARPE-19 cells were pre-treated with 100 μM 2-APB for
ealing assay was used in this study. (D) The quantitative analysis of
cell migration by 2-APB at 24 h and 48 h (both *** p < 0.001).
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24 h and 48 h stimulation with 25 ng/mL
EGF comparing to control were shown in Figure 1B.
The quantifications of cell migration were shown in
Figure 1C.Calcium chelators reduced the EGF-mediated cell
proliferation and migration in the ARPE-19 cells
We next used calcium chelators to clarify the involve-
ment of calcium signaling in EGF-mediated cell growth.
As shown in Figure 2A, both 1 mM EGTA and 2.5 μM
BAPTA-AM significantly inhibited cell proliferation
(***p < 0.001 and **p < 0.01, respectively). In addition,
Figure 2B and 2C demonstrated that EGTA and BAPTA-
AM suppressed cell migration.Expression of STIM1/Orai1 and functional SOC in ARPE-19
cells
RT-PCR and western blot analysis were used to confirm
the existence of Orai1 and STIM1 in the ARPE-19 cells
(Figure 3A and B). SOC signals were detected by a clas-
sical calcium add-back protocol. Calcium stores were de-
pleted by 2 μM thapsigargin (TG). Calcium influx was
observed in the ARPE-19 cells by the addition of 2 mM
calcium (Figure 3C).Figure 5 Knockdown of Orai1 and STIM1 reduced the EGF-mediated c
cells were transfected with Orai1 and STIM1 siRNA. Expression of Orai1 and
ARPE-19 cells transfected with Orai1 and STIM1 siRNA suppressed the 25 n
migration assay was used in the study. (D) Quantitative analysis of cell migThe SOC channel inhibitor 2-APB inhibited EGF-mediated
cell proliferation and migration
2-APB has been widely used to inhibit SOC channels. In
ARPE-19 cells, 2 μM TG evoked calcium influx, and the
addition of 100 μM 2-APB blocked the calcium signals
(Figure 4A), thereby indicating that 2-APB is a reliable
inhibitor of SOC channels. We then pre-treated ARPE-
19 cells with 20–100 μM 2-APB for 30 min, followed by
incubation with 25 ng/mL EGF for 48 h. As shown in
Figure 4B, 100 μM 2-APB significantly inhibited the
EGF-mediated cell proliferation (***p < 0.001). In ad-
dition, 100 μM 2-APB blocked the EGF-mediated cell
migration (Figure 4C and 4D).
Knocking down Orai1 and STIM1 reduced the EGF-
mediated cell proliferation and migration
To further confirm the role of STIM1/Orai1 signaling in
ARPE-19 cells, Orai1 siRNA and STIM1 siRNA were
transfected into the ARPE-19 cells. Orai1 is one of
the major subunits of SOC channels and STIM1 is
the calcium sensor that triggers the activation of SOC
entry. The Orai1 and STIM1 siRNAs reduced expres-
sion of their respective mRNA (Figure 5A(i)) and pro-
tein (Figure 5A(ii)). Importantly, knocking down Orai1
and STIM1 suppressed cell proliferation (*p < 0.05 and
***p < 0.001, respectively; Figure 5B) and migration
(Figure 5C and 5D).ell proliferation and migration in ARPE-19 cells. (A i, ii) ARPE-19
STIM1 was detected by real-time PCR (i) and Western blots (ii). (B-C)
g/mL EGF-induced cell proliferation and migration. WST-1 assay or cell
ration of Figure 5C.
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and cell-cycle progression
To examine the role of STIM1 and Orai1 in EGF-
mediated DNA synthesis and cell-cycle progression, the
cell proliferation ELISA-based BrdU incorporation assay
was used to quantify DNA synthesis in the replicating
cells, and flow cytometry was performed to analyze the
cell-cycle progression. BrdU incorporation was signifi-
cantly reduced following treatment with 100 μM 2-APB
or 20 μM SKF96365 (both *** p < 0.001; Figure 6A) and
by knockdown of Orai1 or STIM1 (both *** p < 0.001;
Figure 6B). As shown in Figure 6C, cell cycle arrested in
the G0/G1 phase in the presence of 20 μM SKF96365
(16 % (EGF) vs. 26.6% (EGF after SKF pre-treatment)).
Mitogen-activated protein kinase kinase (MEK)/ERK 1/2
pathway is involved in EGF-mediated cell proliferation
and migration
The MEK/ERK 1/2 pathway is an important pathway in
proliferation. Pretreatment with MEK inhibitors 20 μM
PD98059 and 10 μM U0126 reduced EGF-mediated
ARPE-19 proliferation (**p < 0.01 and *p < 0.05, respec-
tively; Figure 7A). Importantly, EGF evoked a strong
phosphorylation of ERK 1/2 that was suppressed byFigure 6 Effects of SOC inhibitors and knockdown of Orai1/STIM1 in
were pre-treated by 100 μM 2-APB or 20 μM SKF96365 for 30 min. Cells we
used. (B) ARPE-19 cells were transfected with Orai1 and STIM1 siRNA. The 2
cell-cycle assessed by flow cytometry showed that 25 ng/mL EGF incubation
the 20 μM SKF96365 arrested the cell-cycle in the G0/G1 phase.the MEK inhibitors PD98059 and U0126 (Figure 7B).
Furthermore, pre-treatment with 20 μM PD98059 and
10 μM U0126 reduced the EGF-induced ARPE-19 cell
migration (Figure 7C and 7D). However, pre-treatment
with the SOC channel inhibitors 100 μM 2-APB and
20 μM SKF96365 had no effect on ERK 1/2 phos-
phorylation (Figure 7E), thereby indicating that the
ERK 1/2 phosphorylation was independent of SOC
channel signaling.Phosphatidylinositol 3 kinases (PI3K)/Akt pathway is
involved in EGF-mediated cell proliferation and migration
in ARPE-19 cells
The PI3K/Akt pathway is also an important EGF-
mediated cell proliferation pathway. Pretreatment with
the PI3K inhibitor LY294002 (10 μM) reduced EGF-
mediated cell proliferation (*** p < 0.001; Figure 8A). Im-
portantly, 10 μM LY294002 inhibited phosphorylation
of Akt (Figure 8B) and EGF-mediated cell migration
(Figure 8C and 8D). However, the SOC channel inhibitor
100 μM 2-APB did not suppress EGF-activated Akt
phosphorylation (Figure 8E), indicating that Akt phos-
phorylation was not regulated by SOC channels.BrdU proliferation and cell-cycle progression. (A) ARPE-19 cells
re applied by 25 ng/mL EGF for 24 h. BrdU incorporation assay was
5 ng/mL EGF-induced BrdU incorporation was detected. (C) The
promoted the cell-cycle progression by increasing G2/M percentage, and
Figure 7 EGF induced ARPE-19 proliferation and migration via MEK/ERK 1/2 pathway, independent of SOC channel pathway.
(A) ARPE-19 cells were pre-treated with 20 μM PD98059 or 10 μM U0126 for 30 min and were stimulated by 25 ng/mL EGF for 48 h. WST-1 assay
was performed. (B) Both 20 μM PD98059 and 10 μM U0126 efficiently reduced the ERK 1/2 phosphorylation in ARPE-19 cells evoked by 25 ng/mL
EGF. (C) ARPE-19 cells were applied with 20 μM PD98059 or 10 μM U0126 for 30 min followed by 25 ng/mL EGF for 24 h and 48 h. Migration
assay was performed. (D) Quantitative analysis of cell migration of Figure 7C. (E) Cells were applied by 100 μM 2-APB and 20 μM SKF96365,
EGF-induced ERK 1/2 phosphorylation was determined by Western blots.
Figure 8 PI3K/Akt pathway is involved in EGF-mediated ARPE-19 proliferation and migration, independent of SOC regulation.
(A) ARPE-19 cells were pre-treated with the PI3K inhibitor 10 μM LY294002 for 30 min followed by 25 ng/mL EGF treatment 48 h. Cell proliferation was
detected by WST-1 assay. (B) Cells were applied by 10 μM LY294002. EGF-evoked phosphorylation of Akt was detected by Western blots. (C) ARPE-19
cells were pre-treated by 10 μM LY294002 for 30 min and were stimulated by 25 ng/mL EGF. Cell migration assay was performed. (D) Quantitative
analysis of cell migration of Figure 8C. (E) Cells were pre-treated by 100 μM 2-APB. EGF-induced Akt phosphorylation was examined by Western blots.
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EGF-mediated cell proliferation and migration, but not
via suppressing ERK 1/2 or Akt phosphorylation
To strengthen the role of STIM1/Orai1 signaling in
ARPE-19 cells, another pair of Orai1 siRNA and STIM1
siRNA was transfected into the ARPE-19 cells. The
Orai1 and STIM1 siRNAs reduced expression of RNA
(Figure 9A(i)) and protein (Figure 9A(ii)). Knocking
down Orai1 and STIM1 suppressed cell proliferation
(**p < 0.01 and ***p < 0.001, respectively; Figure 9B) and
migration (Figure 9C and 9D). To clarify the cross-talk
signaling between STIM1/Orai1 and ERK 1/2 or Akt,
the EGF-mediated ERK 1/2 and Akt phosphorylation
were tested after transfection with Orai1 siRNA and
STIM1 siRNA. The knockdown of Orai1 and STIM1 did
not alter the EGF-evoked ERK 1/2 or Akt phosphoryl-
ation in ARPE-19 cells (Figure 9E).
Discussion
The results of the present study demonstrated that EGF
could trigger cell proliferation and migration via STIM1,
Orai1, and phosphorylation of ERK 1/2 and Akt. In RPEFigure 9 Involvement of Orai1 and STIM1 in EGF-mediated cell prolife
another pair of Orai1 and STIM1 siRNA. Expression of Orai1 and STIM1 was
were transfected with Orai1 and STIM1 siRNA. WST-1 assay or cell migration
Figure 9C. (E) ARPE-19 cells were transfected with Orai1 and STIM1 siRNA. E
Western blots.cells, the secretion of VEGF is regulated by calcium
entry through voltage-dependent L-type calcium chan-
nels [16]. Transient receptor potential cation (TRPC)
channels have been reported to involve in the mainten-
ance of basal cellular processes, such as basal secretion
of cytokines [17]. In corneal epithelial cells, TRPC4-
mediated SOC activation is essential in EGF signaling
[18,19]. Combination of molecular biological and elec-
trophysiological approaches, Cordeiro and Strauss repor-
ted a functional SOC channel composed of Orai and
STIM subunits in RPE cells [14].Consistent with the
studies by Cordeiro, our study also confirmed the ex-
pression of Orai1 and STIM1 in the ARPE-19 cells.
Yang et al. reported that STIM1 and Orai1 regulate
the migration and metastasis of breast cancer [20]. In
addition, Chen et al. revealed that STIM1-dependent sig-
naling is important for cervical cancer cell growth, mi-
gration, and angiogenesis [12]. Subsequently, Yoshida
et al. showed that STIM1 knockdown suppressed SOC
entry, cell proliferation, and tumorigenicity in A431 cells
[21]. In our study, we found that ARPE-19 cell proli-
feration and migration were suppressed by the SOCration and migration. (A i, ii) ARPE-19 cells were transfected with
detected by real-time PCR (i) and Western blots (ii). (B-C) ARPE-19 cells
assay was used. (D) Quantitative analysis of ARPE-19 cell migration of
GF-mediated phosphorylation of ERK 1/2 and Akt were detected by
Figure 10 Schematic representation of EGF-mediated ARPE-19
cell proliferation and migration. Functional STIM1, Orai1, and
phosphorylation of ERK 1/2 and Akt, are essential in EGF-induced
RPE cell proliferation and migration.
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against Orai1 or STIM1. The ARPE-19 cells treated
with SKF96365 were arrested in the G0/G1 phase.
The results are similar to previous studies in which
cell proliferation was inhibited by cell cycle arrest in
the G0/G1 phases after manipulation of Orai1/STIM1
signaling [22,23].
Using the cell-attached patch-clamp technique, Ma
et al. were the first to show that EGF stimulates SOC in
both a time-dependent and dose-dependent manner in
human glomerular mesangial cells [10]. Chen et al.
nicely demonstrated that EGF-induced calcium influx is
a STIM1-dependent process that modulates cell growth
in cervical cancer cells [12]. Consistent with this, our
previous study also observed increased calcium signals
evoked by EGF in A431 cancer cells [24]. From the liter-
atures, EGF-mediated intracellular calcium increase is
through a variety of channels [25-27]. However, in our
study, we did not see typical SOC signals evoked by EGF
in ARPE-19 cells (data not shown). Since the involve-
ment of STIM1 and Orai1 in EGF-mediated cell growth
is strongly supported by our study results, we attribute
our lack of typical SOC signals to the complex pattern
of activation of various calcium channels induced by
EGF in ARPE-19 cells.
Phosphorylation of ERK 1/2 and Akt are involved in
cell proliferation [28,29]. Our studies demonstrated
that inhibition of ERK 1/2 phosphorylation by PD98059
and U0126, or inhibition of Akt phosphorylation by
LY294002, suppressed RPE cell proliferation/migration.These findings are consistent with studies by Defoe and
colleagues [30] that revealed the importance of PI3K and
MAPK pathways in EGF signaling in RPE cells. We also
found that SOC channel inhibitors or knockdown of
Orai1 and STIM1 blocked cell proliferation and migra-
tion, but did not influence the phosphorylation levels of
ERK 1/2 and Akt. The regulation of RPE cell prolifera-
tion/migration by EGF remains unclear. Our results in-
dicated that, at least, two distinct proliferative pathways
were regulated by EGF, which control cellular responses.
PVR is the most common complication in patients re-
covering from retinal detachment surgery [31]. The mo-
lecular mechanisms underlying the development of PVR
are still elusive. The involvement of EGF-mediated pro-
liferative pathways in the cellular processes of PVR has
been widely reported [30,32]. Liang et al. indicated that
glucosamine (GlcN) might be useful in the treatment of
EGF-mediated ocular proliferative disorders [33]. These
observations in combination with those of the present
study imply that STIM1/Orai1, MEK/ERK 1/2 and
PI3K/Akt pathways are important mediators of PVR.
More studies are needed to determine the molecular
basis and pathogenesis of PVR in culture cells as well as
animal models.
Conclusions
Our results highlight the importance of STIM1, Orai1,
ERK 1/2 and Akt in EGF-mediated proliferative path-
ways in ARPE-19 cells (Figure 10). EGF plays a key role
in the development of PVR. Our studies revealed that
STIM1, Orai1, and phosphorylation of ERK 1/2 and Akt,
may serve as potential therapeutic targets for future cli-
nical management of PVR.
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